Treatment of acute ischemic stroke by minimally manipulated umbilical cord-derived mesenchymal stem cells transplantation: A case report
STRI, US Patent Registration of the Nerve Cell Differentiation Technology using nEPS (newly Elicited Pluripotent Stem Cell without Side Effects)
[파이낸셜뉴스] 2019.03.28
STRI, US Patent Registration of the Nerve Cell Differentiation Technology using nEPS (newly Elicited Pluripotent Stem Cell without Side Effects)
View Detail: https://www.fnnews.com/news/201903280944121250
Related posts
